Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime

Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime

Abstract Aims Duchenne muscular dystrophy (DMD) is an X‐linked recessive neuromuscular disorder, characterized by significant long‐term cardiac involvement. Dilated cardiomyopathy (DCM) is the main cause of death in DMD, and angiotensin‐converting enzyme inhibitors (ACEi) and beta‐blockers (BB) are...

Full description

Bibliographic Details
Main Authors: Alessandra Arcudi, Marco Di Francesco, Daniele Rodolico, Domenico D'Amario
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:ESC Heart Failure
Subjects:
Duchenne dilated cardiomyopathy
Angiotensin receptor‐neprilysin inhibitor
Ejection fraction
Online Access:https://doi.org/10.1002/ehf2.13963

Similar Items

Similar Items